Skip to content
Echo Pro Media

Patients Stopping Anti-Obesity Injections Gain Back Weight Four Times Faster Compared to Dieters

Image of medical syringe and weighing machine
Weight management often requires ongoing approaches.

Fresh analysis indicates that patients who discontinue popular weight-loss injections like semaglutide or tirzepatide may regain shed pounds at a significantly accelerated pace than those who end traditional diet and exercise regimens.

Research printed in a prominent medical journal shows that while obese individuals can lose a large proportion of their total mass while on the medication, the weight comes back at an average rate of nearly a kilo each month after stopping.

"People buying such medications should be informed of the danger of rapid rebound weight gain when the medication ends," cautioned researcher Dr. Susan Jebb.

Such speed of recovery suggests a return to pre-treatment mass within about 18 months.

Comparing Treatments

The analysis, which reviewed 37 of studies involving over 9,000 of patients, contrasted the results of the injectable medications with other pills.

Researchers note that people who lose weight through dieting typically experience a more gradual weight regain—perhaps 0.1 kg a month—post-intervention.

The Reason for the Fast Rebound

Experts believe the way of the jabs is key to understanding the amplified weight return.

These medications copy a body's own chemical called GLP-1, which moderates appetite.

"Long-term administration of GLP-1 concentrations several times higher than the body's typical production could lead to the body to produce less of its endogenous GLP-1, and could diminish responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert.

"Withdrawal of this medication leads to appetite is no longer kept in check, making binge eating far more likely."

A Lifelong Issue?

Health authorities advise the jabs for people with obesity-related health risks, accompanied by recommended diet and exercise modifications.

A number of clinicians argue that, considering the high risk of weight regain, the therapy might need to be long-term.

This view is echoed by drug manufacturers, who state that the findings "underscore the chronic nature of excess weight," akin to managing conditions like diabetes.

User Accounts

People who have discontinued the jabs report a sudden resurgence of cravings.

"I experienced something activating and I was suddenly starving," recalled one woman.

This difficulty is compounded if users have not developed permanent lifestyle or habit changes during treatment.

Growing Interest

Recent estimates show that millions of adults in the UK have used weight-loss jabs in the last 12 months, with desire remaining high.

  • Use is greater among women than men.
  • The 40s and 50s age group shows the greatest usage rates.
  • A large proportion access the medications through private prescriptions rather than public health services.

Finally, clinicians stress that while the jabs are potent agents for shedding pounds, they are not a magic cure and long-term success likely depends on ongoing behavioural changes.

The writer

Morgan Willis

Maya Sterling is a digital strategist with over 8 years of experience in SEO and social media marketing, specializing in brand storytelling.

Echo Pro Media

Type to search articles.